US2001032016A1PendingUtilityA1

Method for in vitro production of bone

Assignee: ISO TIS N VPriority: Mar 1, 1996Filed: Jun 8, 2001Published: Oct 18, 2001
Est. expiryMar 1, 2016(expired)· nominal 20-yr term from priority
C12N 5/0654A61L 27/3843C12N 2533/18C12N 2502/1311A61L 27/3608A61L 27/3808A61L 27/3834A61L 27/3895A61L 27/365A61L 2430/02C12N 5/0068A61K 2035/124A61L 27/3821
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a method for an vitro production of bone tissue, comprising the steps of: (a) applying undifferentiated mammalian cells, in particular autologous marrow cells, on a substrate; (b) directly contacting said cells with a culture medium for a sufficient time to produce a continuous matrix; (c) removing the substrate with the matrix from the culture medium. The produced matrix can be used for joint prostheses, maxillofacial implants, special surgery devices, or bone fillers. The contacted culture medium can also be used for the production of active factors such as growth factors.

Claims

exact text as granted — not AI-modified
1 . A method for in vitro production of bone tissue, comprising the steps of: 
 (a) applying undifferentiated mammalian cells on a substrate;    (b) directly contacting said cells with a culture medium for a sufficient time to produce a continuous mineralised or non-mineralised matrix having a thickness of at least 0.5 μm;    (c) removing the substrate with the matrix from the culture medium.    
     
     
         2 . A method according to    claim 1   , wherein said undifferentiated mammalian cells are bone marrow cells especially stromal cells.  
     
     
         3 . A method according to    claim 1   , wherein in said cells are autologous cells.  
     
     
         4 . A method according to    claim 1   , wherein in step (a) the cells are applied at a rate of 10 3  to 10 6  cells per cm 2 .  
     
     
         5 . A method according to    claim 1   , wherein the culture medium used in step (b) is a conditioned liquid culture medium.  
     
     
         6 . A method according to    claim 5   , wherein the culture medium used in step (b) is conditioned by prior exposure to viable marrow cells.  
     
     
         7 . A method according to    claim 1   , wherein in step (b) the cells are contacted with the culture medium until a matrix layer of 1-100 μm, in particular of 10-50 μm has been produced.  
     
     
         8 . A method according to    claim 1   , wherein in step (b) the cells are contacted with the culture medium for at least 2 weeks.  
     
     
         9 . A method according to    claim 1   , for the provision of load-bearing implants, joint prostheses, maxillofacial implants or special surgery devices.  
     
     
         10 . A method of producing active factors such as growth factors, comprising the steps of: 
 (a) applying undifferentiated mammalian cells on a substrate;    (b) directly contacting said cells with a culture medium for a sufficient time to produce growth factors:    (c) removing the substrate with the matrix from the culture medium;    (d) recovering the active factors from the culture medium.    
     
     
         11 . A method according to    claim 10   , wherein in step (b) the cells are contacted with the culture medium for at least 2 weeks.  
     
     
         12 . A method of restoring a load-bearing structure in a mammal, including man, comprising introducing a substrate coated with a continuous matrix produced according to    claim 1    as an implant into the site of the structure to be restored.

Join the waitlist — get patent alerts

Track US2001032016A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.